Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
April 30, 2026 21:50 ET | Source: Senseonics Holdings, Inc. GERMANTOWN, Md.,…
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
March 14, 2026 10:15 ET | Source: Senseonics Holdings, Inc. New data…
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
September 03, 2025 17:17 ET | Source: Senseonics Holdings, Inc. CGM commercial…
